Rajan Radha Rasmi and Kunnathur Murugesan Sakthivel (2025) Targeting SREBP2 in cancer progression: Molecular mechanisms, oncogenic crosstalk, and therapeutic interventions. Targeting SREBP2 in cancer progression: Molecular mechanisms, oncogenic crosstalk, and therapeutic interventions, 135. pp. 1-14. ISSN 0898-6568
Kunnathur Murugesan Sakthivel and Rajan Radha Rasmi (2025) Chitin Derivative from Marine Source Artemia francis cana Cysts Inhibits Colorectal Adenocarcinoma Cells by Regulating Apoptotic Mediators. Chitin Derivative from Marine Source Artemia francis cana Cysts Inhibits Colorectal Adenocarcinoma Cells by Regulating Apoptotic Mediators, 17 (3). pp. 973-982.
Kunnathur Murugesan Sakthivel and Rajan Radha Rasmi and Loganathan Chandramani Priya Dharshini and Kalavathi Murugan Kumar and Venugopal Vinod Prabhu and Balasubramanian Ramesh (2025) Nano encapsulated polymeric Scopoletin suppresses the progression of colorectal cancer by regulating cytokines and inflammatory mediators in AOM/DSS murine model. Nano encapsulated polymeric Scopoletin suppresses the progression of colorectal cancer by regulating cytokines and inflammatory mediators in AOM/DSS murine model. pp. 1-10. ISSN 0006-291X
Kunnathur Murugesan Sakthivel and Rasmi Rajan Radha (2025) Histone-Lysine N-Methyltransferase 2D (KMT2D) Impending Therapeutic Target for the Management of Cancer: The Giant Rats Tail. Histone-Lysine N-Methyltransferase 2D (KMT2D) Impending Therapeutic Target for the Management of Cancer: The Giant Rats Tail, 44 (1). pp. 31-36. ISSN 0731-8898
Kunnathur Murugesan Sakthivel (2024) Biosynthesis of chitosan encapsulated silver- nanoparticles using Probiotic-Lactobacillus plantarum strain and it’s in vitro anticancer assessment on HeLa cells. Biosynthesis of chitosan encapsulated silver- nanoparticles using Probiotic-Lactobacillus plantarum strain and it’s in vitro anticancer assessment on HeLa cells: 100117. pp. 1-11. ISSN 2590-0978
Kunnathur Murugesan Sakthivel (2018) Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia. Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia. pp. 85-91. ISSN 0378-1119
Up a level